Linka Group

Selling your clinic is about more than completing a transaction.

For many founders, selling a clinic is one of the most important business decisions they will ever make.

It is about protecting the reputation you have built, supporting the people who helped build it, and ensuring patients continue receiving the same standard of care.

At Linka Group, we acquire established aesthetic, dermatology and specialist medical businesses across the United Kingdom and selectively across Europe.

We believe the strongest businesses deserve long-term stewardship rather than short-term ownership.

About Linka

Every acquisition is approached individually. Some founders choose a complete exit. Others remain involved during a transition period or retain an ongoing ownership interest. We believe transactions work best when they reflect the objectives of both parties rather than following a standard formula.

Linka Group is a healthcare acquisition platform focused on established aesthetic, dermatology and specialist medical businesses.

We seek businesses that have already demonstrated strong clinical standards, loyal patient relationships and consistent financial performance.

Rather than changing what already works, our objective is to strengthen the business through improved financial reporting, governance and access to long-term capital, while preserving the qualities that made it successful in the first place.

ABOUT

WHAT YOU CAN EXPECT FROM US

Long-term ownership

We invest with a long-term perspective and focus on building enduring businesses.

Respect for your legacy

Your reputation, relationships and clinical standards are valuable assets that deserve to be preserved.

Straightforward communication

Important commercial terms are discussed openly before they appear in legal documents.

A disciplined process

Every transaction follows a structured and transparent process designed to minimise disruption and provide certainty.

I

II

IV

III

The Team Behind Linka

Karolis Linkevicius

Leads Linka Group's acquisition strategy, transaction execution and long-term platform development.

Responsible for deal origination, valuation, structuring, negotiation and execution across acquisitions, with a focus on disciplined pricing and downside protection.

LEADERSHIP

CHAIRMAN

FOUNDER & MANAGING DIRECTOR

Dr Pierre A. Morgon

International life sciences executive and board chairman with 40+ years across global pharmaceutical, vaccine and healthcare organisations.

Former senior executive and Executive Committee member at Sanofi Pasteur, with senior leadership experience at Aventis Pasteur and Bristol-Myers Squibb, among others. His career includes operating within global organisations such as Aventis (€17.8bn in annual sales; ~75,000 employees) and Bristol-Myers Squibb ($19.4bn in annual sales; ~43,000 employees).

Brings extensive experience in global operations, cross-border transactions, capital markets and institutional governance.

Provides Linka Group with board-level discipline, transaction oversight, capital markets credibility and strategic leadership.

FINANCIAL LEAD

Karen Sands

CFO with 25+ years of senior finance, M&A and private equity experience, with mandates from leading sponsors including Bain Capital, Montagu Private Equity, Triton Partners and Inflexion.

30+ acquisitions and M&A transactions, with experience across businesses generating £1bn+ in revenue, including a £45m senior debt restructuring within a £767m-revenue international group.

ACA and CTA qualified, with a PhD in IFRS accounting. Karen brings financial oversight, transaction execution and capital-structure expertise to Linka Group's acquisition platform.

Our advisers include experienced legal, tax and financial specialists supporting every transaction from initial discussions through to completion.

PROCESS

Our Acquisition Process

STEP I

Initial conversation

A confidential discussion to understand your objectives and determine whether there is a potential fit.

STEP II

Information review

Following appropriate confidentiality arrangements, we review financial, operational and regulatory information to understand the business.

STEP III

Indicative proposal

Once we understand the business, we present an indicative valuation and proposed transaction structure.

STEP IV

Heads of Terms

Once the principal commercial terms have been agreed, they are documented before detailed due diligence begins.

STEP V

Due diligence

Financial, legal and operational diligence is carried out in a structured and efficient manner, with regular communication throughout.

STEP VI

Completion

Following completion of documentation and satisfaction of agreed conditions, ownership transfers and the agreed transition begin.

A trusted custodian.

OUR COMMITMENT

Every clinic has its own history, culture and objectives.

Our role is not simply to acquire businesses. It is to become a trusted custodian of what the founders have spent years building.

We believe successful transactions are built through preparation, transparency and mutual respect.

You should always know where the process stands, what happens next, and why.